JP2001500130A5 - - Google Patents

Download PDF

Info

Publication number
JP2001500130A5
JP2001500130A5 JP1998513020A JP51302098A JP2001500130A5 JP 2001500130 A5 JP2001500130 A5 JP 2001500130A5 JP 1998513020 A JP1998513020 A JP 1998513020A JP 51302098 A JP51302098 A JP 51302098A JP 2001500130 A5 JP2001500130 A5 JP 2001500130A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1998513020A
Other languages
English (en)
Japanese (ja)
Other versions
JP4975894B2 (ja
JP2001500130A (ja
Filing date
Publication date
Priority claimed from DE19637479A external-priority patent/DE19637479A1/de
Priority claimed from DE19734011A external-priority patent/DE19734011A1/de
Application filed filed Critical
Priority claimed from PCT/EP1997/004984 external-priority patent/WO1998010752A2/de
Publication of JP2001500130A publication Critical patent/JP2001500130A/ja
Publication of JP2001500130A5 publication Critical patent/JP2001500130A5/ja
Application granted granted Critical
Publication of JP4975894B2 publication Critical patent/JP4975894B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP51302098A 1996-09-13 1997-09-11 押出による固体薬剤剤形の製造方法 Expired - Fee Related JP4975894B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE19637479.0 1996-09-13
DE19637479A DE19637479A1 (de) 1996-09-13 1996-09-13 Verfahren zur Herstellung fester pharmazeutischer Formen
DE19734011A DE19734011A1 (de) 1997-08-06 1997-08-06 Verfahren zur Herstellung fester pharmazeutischer Formen
DE19734011.3 1997-08-06
PCT/EP1997/004984 WO1998010752A2 (de) 1996-09-13 1997-09-11 Verfahren zur herstellung fester pharmazeutischer formen durch extrudierung

Publications (3)

Publication Number Publication Date
JP2001500130A JP2001500130A (ja) 2001-01-09
JP2001500130A5 true JP2001500130A5 (enExample) 2005-04-07
JP4975894B2 JP4975894B2 (ja) 2012-07-11

Family

ID=26029370

Family Applications (1)

Application Number Title Priority Date Filing Date
JP51302098A Expired - Fee Related JP4975894B2 (ja) 1996-09-13 1997-09-11 押出による固体薬剤剤形の製造方法

Country Status (19)

Country Link
US (1) US6221368B1 (enExample)
EP (1) EP0930875B1 (enExample)
JP (1) JP4975894B2 (enExample)
KR (1) KR20000036066A (enExample)
CN (1) CN1230109A (enExample)
AT (1) ATE239452T1 (enExample)
AU (1) AU720535B2 (enExample)
BR (1) BR9711777A (enExample)
CA (1) CA2265532C (enExample)
CZ (1) CZ82999A3 (enExample)
DE (1) DE59710059D1 (enExample)
DK (1) DK0930875T3 (enExample)
ES (1) ES2199373T3 (enExample)
HR (1) HRP970485A2 (enExample)
IL (1) IL128672A0 (enExample)
SK (1) SK26099A3 (enExample)
TR (1) TR199900563T2 (enExample)
TW (1) TW474824B (enExample)
WO (1) WO1998010752A2 (enExample)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2241342C (en) 1998-06-15 2000-02-08 Bernard Charles Sherman Pharmaceutical tablets comprising an nsaid and a prostaglandin
DE19857897A1 (de) * 1998-12-15 2000-06-21 Basf Ag Verfahren zur Herstellung wäßriger Polymerdispersionen
US6733789B1 (en) 1999-01-21 2004-05-11 Biovail Laboratories, Inc. Multiparticulate bisoprolol formulation
EP1175205B1 (en) * 1999-11-12 2006-06-14 Abbott Laboratories Solid dispersion comprising ritonavir, fenofibrate or griseofulvin
US7364752B1 (en) 1999-11-12 2008-04-29 Abbott Laboratories Solid dispersion pharamaceutical formulations
US20040185099A1 (en) * 2000-01-20 2004-09-23 Biovail Laboratories, Inc. Multiparticulate bisoprolol formulation
WO2001078721A1 (en) * 2000-04-13 2001-10-25 Mayo Foundation For Medical Education And Research Aβ42 LOWERING AGENTS
DE10026698A1 (de) * 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
GB0106469D0 (en) * 2001-03-15 2001-05-02 Syngenta Ltd Solid formulation
FR2823974B1 (fr) * 2001-04-25 2004-10-15 Pf Medicament Pastille medicamenteuse a liberation lente du principe actif
GB0113841D0 (en) * 2001-06-07 2001-08-01 Boots Co Plc Therapeutic agents
ES2333645T3 (es) * 2001-06-22 2010-02-25 Bend Research, Inc. Composiciones farmaceuticas de dispersiones de medicamentos y polimeros neutros.
US20030091633A1 (en) * 2001-11-15 2003-05-15 John Kelly Methods and compositions for use of (S)-bisoprolol
US20030118652A1 (en) * 2001-11-15 2003-06-26 John Kelly Methods and compositions for use of (S)-bisoprolol
WO2004071431A2 (en) * 2003-02-05 2004-08-26 Myriad Genetics, Inc. Method and composition for treating neurodegenerative disorders
US20060251724A1 (en) * 2003-05-06 2006-11-09 Farrell Thomas P Method for preparing thermoformed compositions containing acrylic polymer binders, pharmaceutical dosage forms and methods of preparing the same
EP1651195A4 (en) * 2003-07-11 2007-10-03 Myriad Genetics Inc PHARMACEUTICAL PROCESSES, DOSIERSCHEMATA AND DOSAGE FORMS FOR THE TREATMENT OF ALZHEIMER DISEASE
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
EP1694304A2 (en) * 2003-12-04 2006-08-30 Pfizer Products Inc. Azithromycin multiparticulate dosage forms by liquid-based processes
JP2007513147A (ja) * 2003-12-04 2007-05-24 ファイザー・プロダクツ・インク 押し出し機を使用して、好ましくはポロキサマーとグリセリドを含有する多粒子結晶性医薬組成物を製造するための噴霧凝結方法
CN1889931A (zh) * 2003-12-04 2007-01-03 辉瑞产品公司 利用挤压器制备优选含泊洛沙姆和甘油酯的多重粒子阿奇霉素组合物的喷雾－冻凝方法
ATE399536T1 (de) * 2003-12-04 2008-07-15 Pfizer Prod Inc Verfahren zur herstellung von pharmazeutischen multiteilchenförmigen produkten
WO2005053639A2 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Controlled release multiparticulates formed with dissolution enhancers
WO2005053652A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
CA2547597A1 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate compositions with improved stability
US6984403B2 (en) * 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects
WO2006001877A2 (en) * 2004-04-13 2006-01-05 Myriad Genetics, Inc. Combination treatment for neurodegenerative disorders comprising r-flurbiprofen
EP1745180A1 (en) * 2004-04-29 2007-01-24 Keystone Retaining Wall Systems, Inc. Veneers for walls, retaining walls and the like
WO2006020853A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020850A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020852A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
US7799744B2 (en) * 2005-03-09 2010-09-21 Halliburton Energy Services, Inc. Polymer coated particulates
WO2007003278A1 (en) 2005-07-05 2007-01-11 Abbott-Gmbh & Co. Kg Composition and dosage form comprising a solid or semi-solid matrix
JP2009502807A (ja) * 2005-07-22 2009-01-29 ミリアド ジェネティクス， インコーポレイテッド 薬剤含有率の高い製剤および投与量形態
EP1832281A1 (en) 2006-03-10 2007-09-12 Abbott GmbH & Co. KG Process for producing a solid dispersion of an active ingredient
US20080033045A1 (en) * 2006-07-07 2008-02-07 Myriad Genetics, Incorporated Treatment of psychiatric disorders
EP2056674A1 (de) * 2006-08-23 2009-05-13 Bayer CropScience AG Formulierungen zur kontrollierten freisetzung agrochemischer wirkstoffe
US8399007B2 (en) * 2006-12-05 2013-03-19 Landec Corporation Method for formulating a controlled-release pharmaceutical formulation
US20090269403A1 (en) * 2008-04-24 2009-10-29 Shaked Ze Ev Oral contraceptive dosage forms and methods of making such dosage forms
US20160113906A1 (en) 2014-09-19 2016-04-28 Board Of Regents, The University Of Texas System Methods of preparing extrudates
CN108421497A (zh) * 2018-04-03 2018-08-21 杨高品 药物连续化制粒的生产工艺和设备
KR20250119038A (ko) 2024-01-31 2025-08-07 주식회사 이엔케이글로벌 신축성재질 성형틀 기반의 고흡수성 고형 제형 흡습제 제조 장비
KR102757752B1 (ko) 2024-01-31 2025-01-21 (주) 제이아리 강성재질 성형틀 기반의 고형 제형 흡습제 제조 장비
KR102857226B1 (ko) 2024-02-01 2025-09-09 (주) 제이아리 고흡수성 고형 제형 흡습제 제조 장비

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1388786A (en) * 1972-04-03 1975-03-26 Scherer Corp R P Integral solid gel-lattice dosage form of high-moisture content
EP0080862B1 (en) * 1981-12-02 1985-09-25 Beecham Group Plc Pharmaceutical formulation comprising beta-lactam antibiotics
DE3208791A1 (de) 1982-03-11 1983-09-22 Röhm GmbH, 6100 Darmstadt Verfahren zum ueberziehen von arzneiformen mittes eines in wasser dispergierten ueberzugsmittels
DE3421860C2 (de) * 1984-06-13 1994-09-15 Roehm Gmbh Verfahren zum Überziehen von Arzneiformen
IL81419A0 (en) * 1986-01-30 1987-08-31 Syntex Inc Long acting sustained release pharmaceutical compositions containing dihydropyridines and their preparation
DE3612211A1 (de) 1986-04-11 1987-10-15 Basf Ag Kontinuierliches verfahren zum tablettieren
DE3612212A1 (de) 1986-04-11 1987-10-15 Basf Ag Verfahren zur herstellung von festen pharmazeutischen formen
JPS63222112A (ja) 1987-03-10 1988-09-16 Nippon Soda Co Ltd 徐放性顆粒
JPS63222121A (ja) * 1987-03-10 1988-09-16 Nippon Soda Co Ltd 徐放性ゲル製剤
DE3812567A1 (de) 1988-04-15 1989-10-26 Basf Ag Verfahren zur herstellung pharmazeutischer mischungen
DE3830353A1 (de) 1988-09-07 1990-03-15 Basf Ag Verfahren zur kontinuierlichen herstellung von festen pharmazeutischen formen
DE4031881C2 (de) 1990-10-08 1994-02-24 Sanol Arznei Schwarz Gmbh Lösungsmittelfreie, oral zu verabreichende pharmazeutische Zubereitung mit verzögerter Wirkstoffreisetzung und Verfahren zu deren Herstellung
GB9025372D0 (en) 1990-11-22 1991-01-09 Nat Res Dev Pharmaceutical dosage forms
NL9100691A (nl) * 1991-04-19 1992-11-16 Dmv Campina Bv Tabletteerhulpstof.
DE4138513A1 (de) * 1991-11-23 1993-05-27 Basf Ag Feste pharmazeutische retardform
DE4141268A1 (de) 1991-12-14 1993-06-17 Merck Patent Gmbh Pharmazeutische zubereitung
US5260074A (en) * 1992-06-22 1993-11-09 Digestive Care Inc. Compositions of digestive enzymes and salts of bile acids and process for preparation thereof
JPH06218028A (ja) 1992-10-02 1994-08-09 Eisai Co Ltd 湿製錠の成型方法とその装置及び湿製錠
EP0729748B1 (en) 1993-11-18 2003-02-26 Nippon Shinyaku Company, Limited Process for producing stable medicinal composition
EP0739198B1 (en) * 1994-01-20 2003-09-17 Agresearch Limited Device for administration of beneficial materials to ruminants
US6787156B1 (en) * 1994-02-23 2004-09-07 Bm Research A/S Controlled release composition

Similar Documents

Publication Publication Date Title
JP2001514483A5 (enExample)
JP2000502280A5 (enExample)
JP2000501771A5 (enExample)
JP2001502505A5 (enExample)
JP2000501599A5 (enExample)
JP2001503896A5 (enExample)
JP2001504614A5 (enExample)
JP2002515145A5 (enExample)
JP2000502472A5 (enExample)
JP2000501825A5 (enExample)
JP2000500874A5 (enExample)
JP2000502425A5 (enExample)
JP2000502485A5 (enExample)
JP2001500130A5 (enExample)
JP2000502568A5 (enExample)
JP2000501774A5 (enExample)
JP2000512342A5 (enExample)
JP2000502570A5 (enExample)
JP2000501876A5 (enExample)
JP2000511663A5 (enExample)
JP2001501883A5 (enExample)
JP2000501744A5 (enExample)
JP2000502316A5 (enExample)
JP2000502714A5 (enExample)
JP2000500318A5 (enExample)